NEXGEL, Inc. (NXGL) NASDAQ
0.59
-0.0336(-5.38%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.59
-0.0336(-5.38%)
Currency In USD
| Previous Close | 0.62 |
| Open | 0.62 |
| Day High | 0.66 |
| Day Low | 0.59 |
| 52-Week High | 3.02 |
| 52-Week Low | 0.58 |
| Volume | 46,384 |
| Average Volume | 259,970 |
| Market Cap | 6.3M |
| PE | -1.56 |
| EPS | -0.38 |
| Moving Average 50 Days | 1.09 |
| Moving Average 200 Days | 1.94 |
| Change | -0.03 |
Data not available
NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-Stage Regenerative Biomaterial Products
GlobeNewswire Inc.
Mar 10, 2026 12:45 PM GMT
Transaction expected to approximately triple NEXGEL’s annual revenue to about $35 million and is expected to make the Company immediately profitable upon closing Licensing and acquiring a diversified suite of 6 established regenerative biomaterial pr
NEXGEL Announces Financing of $1.797 Million Relating to an Acquisition Targeted to Close in the First Quarter of 2026, Subject to the Completion of Due Diligence
GlobeNewswire Inc.
Feb 10, 2026 2:00 PM GMT
LANGHORNE, Pa., Feb. 10, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products
NexGelRx Receives Additional Investment from Eric Gruntfest of Diesis Holdings, LLC and Appoints Him as Board Observer and Strategic Advisor
GlobeNewswire Inc.
Dec 16, 2025 1:00 PM GMT
LANGHORNE, Pa., Dec. 16, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products